Patent · US Active

Testing for neurovascular uncoupling in multiple sclerosis using sequential gas delivery versus fixed inspired CO2

US11998351B2 · kind B2 · utility

0Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 21, 2020
Grant dateJun 4, 2024
Priority date
Expiry dateApr 6, 2043

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01R33/56366
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

An apparatus and method for assessing vascular compliance in subjects with multiple sclerosis using sequential gas delivery is provided. The apparatus includes a gas delivery device and a processor. The processor controls the gas delivery device to deliver a first and second gas during a single inspiration. The first gas contains a mixture of oxygen and carbon dioxide necessary to target an end-tidal concentration of the two gases. The second gas includes a concentration of carbon dioxide equal to the target end-tidal concentration of carbon dioxide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.